Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AirMedia Group Inc stock logo
ANTE
AirMedia Group
$3.66
-1.6%
$3.95
$0.54
$6.69
$52.46M1.66397,974 shs305,623 shs
eGain Corporation stock logo
EGAN
eGain
$7.50
-0.1%
$6.89
$5.81
$15.95
$206.15M0.81119,838 shs74,649 shs
Perfect Corp. stock logo
PERF
Perfect
$1.87
-0.5%
$1.80
$1.24
$2.16
$191.48M0.28388,712 shs52,610 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$3.94
-5.3%
$8.30
$3.77
$21.41
$213.96M-0.2405,397 shs248,921 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AirMedia Group Inc stock logo
ANTE
AirMedia Group
0.00%0.00%0.00%0.00%+81.19%
eGain Corporation stock logo
EGAN
eGain
-0.13%+2.32%+12.61%+15.56%+21.36%
Perfect Corp. stock logo
PERF
Perfect
0.00%-2.09%-2.86%+10.00%-1.58%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-5.29%-2.48%-23.79%-57.41%-63.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AirMedia Group Inc stock logo
ANTE
AirMedia Group
$3.66
-1.6%
$3.95
$0.54
$6.69
$52.46M1.66397,974 shs305,623 shs
eGain Corporation stock logo
EGAN
eGain
$7.50
-0.1%
$6.89
$5.81
$15.95
$206.15M0.81119,838 shs74,649 shs
Perfect Corp. stock logo
PERF
Perfect
$1.87
-0.5%
$1.80
$1.24
$2.16
$191.48M0.28388,712 shs52,610 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$3.94
-5.3%
$8.30
$3.77
$21.41
$213.96M-0.2405,397 shs248,921 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AirMedia Group Inc stock logo
ANTE
AirMedia Group
0.00%0.00%0.00%0.00%+81.19%
eGain Corporation stock logo
EGAN
eGain
-0.13%+2.32%+12.61%+15.56%+21.36%
Perfect Corp. stock logo
PERF
Perfect
0.00%-2.09%-2.86%+10.00%-1.58%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-5.29%-2.48%-23.79%-57.41%-63.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AirMedia Group Inc stock logo
ANTE
AirMedia Group
0.00
N/AN/AN/A
eGain Corporation stock logo
EGAN
eGain
2.25
Hold$15.25103.33% Upside
Perfect Corp. stock logo
PERF
Perfect
1.67
ReduceN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest ANTE, ZSQR, EGAN, and PERF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
eGain Corporation stock logo
EGAN
eGain
Reiterated RatingHold (C)
7/17/2026
Perfect Corp. stock logo
PERF
Perfect
Reiterated RatingSell (D)
(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AirMedia Group Inc stock logo
ANTE
AirMedia Group
$343K152.94N/AN/A($1.54) per share-2.38
eGain Corporation stock logo
EGAN
eGain
$88.43M2.33$0.22 per share33.44$2.95 per share2.54
Perfect Corp. stock logo
PERF
Perfect
$69.15M2.75$0.06 per share33.84$1.54 per share1.21
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$1.36M149.00N/AN/A$2.63 per share1.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AirMedia Group Inc stock logo
ANTE
AirMedia Group
-$13.65MN/AN/AN/AN/AN/AN/AN/AN/A
eGain Corporation stock logo
EGAN
eGain
$32.25M$1.385.4325.00N/A41.68%12.56%7.48%9/3/2026 (Estimated)
Perfect Corp. stock logo
PERF
Perfect
$4.64M$0.0631.1720.781.298.13%3.73%2.98%N/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-$11.92M-$2.52N/AN/AN/A-773.72%-152.53%-129.53%N/A

Latest ANTE, ZSQR, EGAN, and PERF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/3/2026Q4 2026
eGain Corporation stock logo
EGAN
eGain
$0.04N/AN/AN/A$21.75 millionN/A
8/13/2026Q2 2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A-$0.28N/A-$0.28N/AN/A
7/27/2026Q2 2026
Perfect Corp. stock logo
PERF
Perfect
$0.01$0.0130+$0.0030$0.0130N/A$16.34 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AirMedia Group Inc stock logo
ANTE
AirMedia Group
N/AN/AN/AN/AN/A
eGain Corporation stock logo
EGAN
eGain
N/AN/AN/AN/AN/A
Perfect Corp. stock logo
PERF
Perfect
N/AN/AN/AN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AirMedia Group Inc stock logo
ANTE
AirMedia Group
N/A
0.33
0.33
eGain Corporation stock logo
EGAN
eGain
N/A
2.15
2.15
Perfect Corp. stock logo
PERF
Perfect
N/A
4.63
4.63
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
0.01
3.25
3.25

Institutional Ownership

CompanyInstitutional Ownership
AirMedia Group Inc stock logo
ANTE
AirMedia Group
1.02%
eGain Corporation stock logo
EGAN
eGain
53.94%
Perfect Corp. stock logo
PERF
Perfect
N/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
13.88%

Insider Ownership

CompanyInsider Ownership
AirMedia Group Inc stock logo
ANTE
AirMedia Group
7.50%
eGain Corporation stock logo
EGAN
eGain
38.70%
Perfect Corp. stock logo
PERF
Perfect
44.70%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
24.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
AirMedia Group Inc stock logo
ANTE
AirMedia Group
7014.33 million13.26 millionNot Optionable
eGain Corporation stock logo
EGAN
eGain
69027.45 million16.83 millionOptionable
Perfect Corp. stock logo
PERF
Perfect
N/A101.85 million56.32 millionN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
251.43 million38.96 millionNot Optionable

Recent News About These Companies

Z Squared Inc. Provides Capital Structure Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AirMedia Group stock logo

AirMedia Group NASDAQ:ANTE

AirNet Technology Inc., together with its subsidiaries, operates out-of-home advertising networks in the People's Republic of China. It provides in-flight solutions to connectivity, entertainment, and digital multimedia; in-flight entertainment and advertising contents, including sports, comedies, local attractions, reality shows, commentaries, documentaries, and copyrighted entertainment contents; and internet connections through a network of satellites and land-based beacons. The company also offers advertising time slots in the form of digital TV screens on airplanes; and media contents display in air travel. In addition, it operates CIBN-AirNet channel to broadcast network TV programs to air travelers. The company was formerly known as AirMedia Group Inc. and changed its name to AirNet Technology Inc. in May 2019. AirNet Technology Inc. was founded in 2005 and is headquartered in Beijing, the People's Republic of China.

eGain stock logo

eGain NASDAQ:EGAN

$7.50 -0.01 (-0.13%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$7.49 -0.01 (-0.13%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

eGain Corporation develops, licenses, implements, and supports customer service infrastructure software solutions in North America, Europe, the Middle East, Africa, and the Asia Pacific. It provides eGain Knowledge Hub, which helps businesses to centralize knowledge, policies, procedures, situational expertise, best-practices, while delivering guided, and personalized solutions to customers and agents; eGain Conversation Hub for digital-first, omnichannel interaction management within a modern, purpose-built desktop; and eGain Analytics Hub enables clients to measure, manage, and optimize omnichannel service operations and knowledge. The company also offers subscription services that provides customers with access to its software on a cloud-based platform; and professional services, such as consulting and implementation, training, and managed services. It serves customers in various industry sectors, including the financial services, telecommunications, retail, government, healthcare, and utilities. The company was incorporated in 1997 and is headquartered in Sunnyvale, California.

Perfect stock logo

Perfect NYSE:PERF

$1.87 -0.01 (-0.53%)
As of 08/14/2026 03:58 PM Eastern

Perfect Corp. is a software as a service technology company, which engages in the business of developing makeup virtual try-on solutions. Its solutions include virtual try-ons for makeup, nail art, hairstyles, beard dye and styling, eyewear, jewelry, advanced skin diagnostic technology, foundation shade finder, and interactive artificial reality makeup application tutorial platform. Its brands include Estée Lauder, Clinique, MAC, e.l.e., benefit, Sally Hansen, Belcorp, Decorté, NARS, Aveda, Madisonreed, kate, Sofina iP, Jillstuart, Cosnova, Beekman, Marianna, Ardell, tarte, and Coffret D’or. It operates through the following geographical segments: United States, Japan, France, and Others. The company was founded by Alice H. Chang on February 13, 2015 and is headquartered in New Taipei, Taiwan.

Coeptis Therapeutics stock logo

Coeptis Therapeutics NASDAQ:ZSQR

$3.94 -0.22 (-5.29%)
As of 08/14/2026 04:00 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.